Ramón
Lecumberri Villamediana
Consultor Médico
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublications en collaboration avec des chercheurs de Hospital de la Santa Creu i Sant Pau (13)
2024
-
Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing
Clinical and Translational Oncology
-
Profilaxis de la enfermedad tromboembólica venosa en pacientes hospitalizados por patología médica desde los servicios de urgencias españoles: estudio PROTESU II
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 4, pp. 271-280
2023
-
Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning
Thrombosis Research, Vol. 228, pp. 181-188
2022
-
Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH–SETH
Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 770-783
-
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients
Leukemia and Lymphoma, Vol. 63, Núm. 3, pp. 538-550
-
Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial
Thrombosis and Haemostasis, Vol. 122, Núm. 2, pp. 295-299
2021
-
Characteristics of isolated superficial vein thrombosis and diagnostic-therapeutic management in spanish hospital emergency departments:The altamira study
Emergencias, Vol. 33, Núm. 6, pp. 433-440
2018
-
Cancer-associated thrombosis: Beyond clinical practice guidelines-A multidisciplinary (SEMI-SEOM-SETH) expert consensus
TH Open, Vol. 2, Núm. 4, pp. e373-e386
2017
-
Clinical perspectives on the management of bleeding in patients on oral anticoagulants: The DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsa
Emergencias, Vol. 29, Núm. 1, pp. 18-26
-
FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence
Clinical and Translational Oncology, Vol. 19, Núm. 8, pp. 997-1009
2015
-
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry
Thrombosis Journal, Vol. 13, Núm. 1
2008
-
AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms
Haematologica, Vol. 93, Núm. 5, pp. 729-734
2007
-
Antithrombin Cambridge II (A384S): An underestimated genetic risk factor for venous thrombosis
Blood, Vol. 109, Núm. 10, pp. 4258-4263